Zobrazeno 1 - 10
of 28
pro vyhledávání: '"N J, Olsen"'
Publikováno v:
The British journal of dermatology. 166(1)
Up to 28% of patients with discoid lupus erythematosus (DLE) are susceptible to developing systemic lupus erythematosus (SLE). To better characterize patients with DLE who have a higher potential of developing SLE, we reviewed studies contrasting, fi
Autor:
N J, Olsen
Publikováno v:
Minerva medica. 102(1)
Osteoarthritis (OA) is a highly prevalent human condition which is becoming an even greater health problem in an aging global population. Existing treatments for OA provide pain relief and some anti-inflammatory effects, but no truly disease-modifyin
Publikováno v:
Clinical and experimental rheumatology. 29(4)
Although oligoarticular juvenile idiopathic arthritis (oJIA) is considered to carry the best prognosis among the JIA subtypes, many children evolve to a chronic course. A few studies have identified clinical risk factors for disease extension, and re
Publikováno v:
Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology. 35(12)
Atopic diseases, resulting from hypersensitivity to a wide variety of allergens, affect 10-20% of the population. Immunotherapy is an effective treatment for atopic diseases, but its mechanisms are not fully understood.We studied gene expression prof
Autor:
J H, Park, K J, Niermann, N M, Ryder, A E, Nelson, A, Das, A R, Lawton, M, Hernanz-Schulman, N J, Olsen
Publikováno v:
Arthritis and rheumatism. 43(10)
To characterize metabolic abnormalities in the muscles of children with the juvenile variant of dermatomyositis (JDM) by the use of noninvasive P-31 magnetic resonance spectroscopy (MRS).Thirteen patients with JDM (ages 4-16 years) were studied. Bioc
Autor:
E W, St Clair, S B, Cohen, M L, Lee, R M, Fleischmann, S H, Lee, L W, Moreland, N J, Olsen, P W, Pratt, D E, Yocum, L, Heck, J, Winkelhake, J S, Holcenberg, M J, Shulman
Publikováno v:
The Journal of rheumatology. 27(8)
To determine the safety and potential clinical efficacy of primary and booster injections of a DR4/1 peptide in patients with active rheumatoid arthritis (RA) despite methotrexate therapy. METHODS. Subjects with active RA were enrolled in a randomize
Publikováno v:
Bulletin on the rheumatic diseases. 48(8)
Leflunomide treatment appears to offer an alternative to methotrexate and sulfasalazine and is a welcome addition to the therapeutic armamentarium for treating active RA. Leflunomide treatment for more than 12 months results in clinically meaningful
Publikováno v:
NMR in biomedicine. 11(4-5)
Classical myopathic dermatomyositis (DM) is a chronic autoimmune disease characterized by an erythematous rash and severe, proximal muscle weakness. A disease variant, amyopathic DM, presents with the typical rash but without clinical evidence of mus
Publikováno v:
Arthritis and rheumatism. 41(3)
To investigate the metabolic and functional status of muscles of fibromyalgia (FM) patients, using P-31 magnetic resonance spectroscopy (MRS).Twelve patients with FM and 11 healthy subjects were studied. Clinical status was assessed by questionnaire.
Autor:
A W, Musk, N H, de Klerk, G L, Ambrosini, J L, Eccles, J, Hansen, N J, Olsen, V L, Watts, H G, Lund, S C, Pang, J, Beilby, M S, Hobbs
Publikováno v:
International journal of cancer. 75(3)
Our aim was to describe a vitamin A-based cancer prevention program for former asbestos workers and to check for possible harmful effects by comparing rates of disease and death in study subjects with subjects who chose not to join. All subjects had